Business

Chimeric opens CHM CDH17 Phase 1/2 trial

Chimeric opens CHM CDH17 Phase 1/2 trial

Chimeric Therapeutics LimitedMay 22, 20245
Chimeric opens CHM CDH17 Phase 1/2 trial

About this update from Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Chimeric Therapeutics Limited

More from Chimeric Therapeutics Limited

All Chimeric Therapeutics Limited news →